États-Unis · Plateformes & données · Seeking Alpha

Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum

Publié par Seeking Alpha · États-Unis il y a 48 min

Résumé détaillé

MariMed posts record Q3 2026 revenue of $44.2 million, up 8.5% year over year, with $4.7 million adjusted EBITDA and $3.5 million operating cash flow.

Lire l'article complet sur Seeking Alpha Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (seekingalpha.com)

Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum

Résumé détaillé

À lire aussi

Should a widow leave her late partner’s home to her stepkids — or cut off contact with them?

Twist Bioscience (NASDAQ:TWST) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

High Roller Technologies Inks Agreement with ProphetX to Expand Event Contracts Offering Through ROLR

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Oil prices mixed after Trump says no Iran deal needed: 'We've got their Strait'

Spectrum plans significant changes as more customers leave

Marimed targets New York launch in H1 2027 with $4B market opportunity as record $44.2M quarter extends momentum

Résumé détaillé

Partager

À lire aussi

Should a widow leave her late partner’s home to her stepkids — or cut off contact with them?

Twist Bioscience (NASDAQ:TWST) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

High Roller Technologies Inks Agreement with ProphetX to Expand Event Contracts Offering Through ROLR

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Oil prices mixed after Trump says no Iran deal needed: 'We've got their Strait'

Spectrum plans significant changes as more customers leave